AVITA Medical Inc (RCEL): Enterprise Value to EBITDA Ratio

Graphic logo of avitamedical.com (RCEL)

AVITA Medical, Inc. (RCEL) is a leader in skin restoration utilizing the innovative Recell system. Business development relies on the implementation of automation for clinics and the expansion into new therapeutic areas, including the treatment of scars and vitiligo. High demand for the treatment of injuries and burns is accelerating revenue growth, while profit expectations are already priced in. The market valuation dynamics of the asset at 0.00 confirm management's professionalism in scaling physician training.

AVITA Medical Inc. - RCEL Total Company Value to Operating Income Before Depreciation Ratio (period 11/23/2025 - 11/12/2026)

Comprehensive metric breakdowns and analytics for avitamedical.com (RCEL)

- stock price and consensus target price:
Stock Quotes AVITA Medical, Inc|RCEL - Analyst Consensus Forecast
- stock exchange capitalization data:
Market Valuation AVITA Medical Inc|RCEL - Aggregate Business Value
- business book valuation details:
Book Value per Share AVITA Medical|RCEL - Book Valuation of Business|Market Capitalization to Book Value Ratio avitamedical.com|RCEL - Cumulative Company Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio AVITA Medical, Inc.|RCEL - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity AVITA Medical|RCEL - Company Total Debt|Debts to Book Capitalization AVITA Medical Inc|RCEL - Long-Term Debt|Company Short-Term Debts AVITA Medical|Quick Ratio avitamedical.com
- financial results and valuation multiples details:
RCEL - Net Financial Result|Projected Future Earnings AVITA Medical, Inc.|RCEL - Price to Earnings Ratio|Forward P/E Multiple AVITA Medical, Inc.|RCEL - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AVITA Medical Inc|RCEL - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months AVITA Medical|RCEL - Earnings per share for the trailing year|Quarterly EPS earnings growth avitamedical.com|RCEL - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year AVITA Medical, Inc.
Analysis of all company metrics:AVITA Medical, Inc RCEL
Manufactured products of AVITA Medical

The development of the RECELL system through clinic partnerships requires significant capital expenditures in equipment. The enterprise value to EBITDA (EV/EBITDA) ratio allows for an assessment of the efficiency of these investments by excluding the impact of taxes and debt load. By analyzing the EV/EBITDA valuation trend for AVITA Medical, Inc. (RCEL), an investor can determine the real value of assets relative to the generated cash flow. This confirms the validity of the market capitalization of AVITA Medical, Inc. (RCEL) as the business scales.

Competitor analysis

Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|SNWV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OM|ELMD (SmartVest) - EV/EBITDA Multiple|LENSAR Inc. (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PROF|Enterprise Value to EBITDA Ratio bairdmed.com BDMD|EV/EBITDA Multiple EDAP (EDAP TMS)|EV/EBITDA Multiple Apyx Medical Corp APYX|ICCM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (telabio.com) - Enterprise Value to EBITDA Ratio|CytoSorbents Corporation - Business Value to Operating Income Before Depreciation|SRTS (Sensus Healthcare, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA zynex.com ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore, Inc. (ECOR)|vicarioussurgical.com (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple SeaStar Medical Holding Corp. ICU|IRIDEX Corp. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions INBS|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|cutera.com (CUTR) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio KNW|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NARI|EV/EBITDA Multiple NVRO|Total Company Value to Operating Income Before Depreciation Ratio reshapelifesciences.com|Silk Road Medical, Inc - Enterprise Value to EBITDA Ratio